Insufficient Data
Insufficient Data
Stock doesn't offer attractive dividend returns
Good time to consider, as stock is not in overbought zone
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
—
—
—
Panacea Biotec Limited is a health management company. The Company's principal business activity is the manufacture of allopathic pharmaceuticals preparations.
Customise key metrics, see detailed forecasts, download stock data and more
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Panacea Biotec Limited has informed the Exchange regarding a press release dated January 17, 2023, titled "Panacea Biotec donates 125,000 doses of Easyfive-TT (DTwP-HepB-Hib) a fully liquid Pentavalent vaccine to Ministry of Health, Republic of Cuba for use in the National Health System". | Download
Panacea Biotec Limited has informed the Exchange regarding a press release dated January 17, 2023, titled "Panacea Biotec donates 125,000 doses of Easyfive-TT (DTwP-HepB-Hib) a fully liquid Pentavalent vaccine to Ministry of Health, Republic of Cuba for use in the National Health System". | Download
Panacea Biotec Limited has informed the Exchange about details of securities dematerialised during the quarter ended December 31, 2022 under SEBI (Depositories and Participants) Regulations, 2018 | Download
Panacea Biotec Limited has informed the Exchange about details of securities dematerialised during the quarter ended December 31, 2022 under SEBI (Depositories and Participants) Regulations, 2018 | Download
Final • Div/Share: ₹ 0.75
Intrinsic valueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Insufficient Data